## Abstract To improve functionality and performance, controlled drugβrelease coatings comprised of drug and polymer are integrated with traditional medical devices, e.g., drug eluting stents. Depending on manufacturing conditions, these coatings can exhibit complex microstructures. Previously, a t
Modeling microstructure development and release kinetics in controlled drug release coatings
β Scribed by David M. Saylor; Chang-Soo Kim; Dinesh V. Patwardhan; James A. Warren
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 543 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A scaffoldβcoating design, the hydroxyapatite (HA) porous bone scaffold coated with poly(Ο΅β)caprolactone (PCL) and HA powder hybrids, was developed for use as tissueβregeneration and controlledβrelease system. An antibiotic drug, tetracycline hydrochloride (TCH), was encapsulated within
## Abstract Biodegradable polymeric coatings on cardiovascular stents can be used for local delivery of therapeutic agents to diseased coronary arteries after stenting procedures. This can minimize the occurrence of clinically adverse events such as restenosis after stent implantation. A validated